Regenerative Medical Technology (RMTG) EV to EBITDA (2024 - 2026)
Regenerative Medical Technology's EV to EBITDA came in at -1.56 for Q2 2026, compared with -2.46 a year earlier.
Powered by 
Analysis
Regenerative Medical Technology (RMTG) EV to EBITDA (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Regenerative Medical Technology reported EV to EBITDA of -9.44; for FY2024, it was -2.62.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Regenerative Medical Technology | 824,338.06 | -3.70 Mn | 2.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.56 |
| Jun 30, 2025 | -2.46 |
| Mar 31, 2025 | -1.64 |
| Dec 31, 2024 | -2.62 |
API Access
Regenerative Medical Technology EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=RMTG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "RMTG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=RMTG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();